|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,270,000 |
Market
Cap: |
161.55(M) |
Last
Volume: |
1,216,843 |
Avg
Vol: |
702,721 |
52
Week Range: |
$1.49 - $4.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 7.8 |
Insider 6 Months : 7.8 |
Insider 3/6 Months : 16 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
100,000 |
100,000 |
100,000 |
100,000 |
Total Buy Value |
$156,045 |
$156,045 |
$156,045 |
$156,045 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
2 |
2 |
2 |
2 |
Total Shares Sold |
0 |
28,236 |
254,432 |
445,755 |
Total Sell Value |
$0 |
$75,586 |
$667,103 |
$1,119,320 |
Total People Sold |
0 |
3 |
7 |
8 |
Total Sell Transactions |
0 |
3 |
16 |
34 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Nouri Alaleh |
SVP, General Counsel & |
|
2014-08-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
76,052 |
|
- |
|
Londy Kelly |
EVP Chief Commercial Officer |
|
2014-06-30 |
4 |
GD |
$0.00 |
$0 |
D/D |
100 |
121,891 |
|
- |
|
Nouri Alaleh |
VP, Interim General Counsel |
|
2014-05-30 |
4 |
A |
$6.54 |
$12,229 |
D/D |
1,871 |
66,052 |
|
- |
|
Levine Joshua |
President & CEO |
|
2014-05-06 |
4 |
B |
$8.15 |
$407,500 |
D/D |
50,000 |
531,210 |
2.74 |
- |
|
Londy Kelly |
EVP Chief Commercial Officer |
|
2014-04-30 |
4 |
D |
$8.40 |
$39,572 |
D/D |
(4,711) |
121,991 |
|
- |
|
380 Records found
|
|
Page 16 of 16 |
|
|